Tenet Healthcare Corporation (THC) is listed among the 10 Cheap Stocks With Strong Buy Ratings on Wall Street. Morgan Stanley reiterated its Overweight rating on THC with a $247 price target, and Guggenheim also maintained a Buy rating with a price target of $257. THC’s positive momentum is driven by Q3 2025 results showing a year-over-year increase in adjusted EBITDA of over 12% and raised guidance for 2025. Analysts see THC’s strong performance in ambulatory care as outweighing sector risks. THC is a U.S. healthcare services company with a network of hospitals, surgery centers, and outpatient facilities.

Read more at Yahoo Finance: Ambulatory Care Drives Tenet Healthcare Corporation (THC)’s Strong Earnings Momentum